BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Newcastle Hospitals Clinical Skills Academy - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://skillsacademy.newcastle-hospitals.nhs.uk
X-WR-CALDESC:Events for Newcastle Hospitals Clinical Skills Academy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260317T133000
DTEND;TZID=Europe/London:20260324T163000
DTSTAMP:20260404T180508
CREATED:20250922T141230Z
LAST-MODIFIED:20250922T164722Z
UID:10000128-1773754200-1774369800@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Targeted treatments and immunotherapy for Breast Cancer
DESCRIPTION:Delivered over two\, two-hour sessions\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will guide you through many of the most relevant topics relating to modern systemic treatments for breast cancer. \nElaine first looks at why cancers arise – through the accumulation of gene mutations affecting important genes. She also looks at other vital factors in breast cancer – hormones\, and the vigilance of the person’s immune system and also looks at the challenges we face in classifying breast cancer and the reasons why breast cancer might spread to other parts of the body. \nElaine then dives into the mechanisms of action of hormone therapies for breast cancer and looks at new treatments being developed. \nIn the second session\, Elaine looks at HER2-positive and triple-negative breast cancer. She explains what HER2 is\, and what features make it an almost-ideal target for treatments. After describing various such treatments\, Elaine explains why resistance can happen and how it might be overcome. \nElaine then discusses triple-negative breast cancer\, which is\, in fact\, a diverse group of diseases. She describes the progress made to date in developing more effective treatments. \nAudience\nDr Vickers’ goal is to explain the science that underpins each treatment. She also hopes to provide learners with a broad understanding of why treatments work well for some patients but not for others. \nThis half day course is ideal for research nurses\, clinical nurse specialists\, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with breast cancer\, and to junior doctors. \nACCEND\nNHS England’s ACCEND Programme aims to support the development of a skilled and knowledgeable cancer workforce. \nThis course supports Component 3 of the ACCEND pathway\, the Education Framework. \nSpecifically\, this course’s objectives and learning outcomes meet core cancer knowledge needs at both the ‘Foundation of Cancer Care’ and ‘Fundamentals of Cancer Care’ levels. \nThe course will enhance learners’ understanding of cancer biology\, the mechanism of action of systemic cancer treatments\, and the use of biomarkers to select the best treatments for each patient. \nThe knowledge gained through this course will empower staff to feel confident when communicating with patients and their families\, and with clinical and non-clinical colleagues. \nDetailed description\nSession 1\nPresentation 1 – Introduction to breast cancer \n\nHow breast cancer arises\nWho’s most at risk?\nHow should we classify breast cancer?\nCommon mutations in breast cancer cells\nHow\, when and why breast cancer spreads\nWho’s at risk of their cancer returning\n\nPresentation 2 – Treatments for hormone receptor-positive breast cancer \n\nHormone receptors and hormone therapies\nWhy combine hormone therapy with CDK inhibitors?\nCauses of resistance to hormone therapies\nTargeting the PI3K/AKT/mTOR pathway\nNovel hormone therapies: SERDs and PROTACs\n\nSession 2\nPresentation 3 – Treatments for HER2-positive breast cancer \n\nWhat is HER2?\nTargeting HER2\nAntibody-based treatments – naked antibodies and antibody-drug conjugates\nHER2-targeted kinase inhibitors\nOvercoming resistance to HER2-targeted treatments\nHER2-low breast cancer\n\nPresentation 4 – Treatments for triple-negative breast cancer \n\nIntroduction to triple-negative breast cancer\nImmunotherapy with checkpoint inhibitors\nSacituzumab govitecan and other antibody-drug conjugates\nPARP inhibitors for BRCA-mutated breast cancer\n\nPre-course preparation\nElaine has created two YouTube playlists about cancer biology and cancer treatments to help learners get the most out of her courses. Each playlist contains 10 videos between 3 and 8 minutes long. \nElaine also advises: “If you’re short on time and you’re not sure about the relationship between DNA\, genes and proteins\, I would suggest watching the Cells\, DNA\, genes and chromosomes and From genes to proteins videos from the Cancer Basics playlist as a priority. Also\, if you’re new to cancer\, I’d recommend the Mutations cause cancer video and\, in order to understand how cancer cells interact with the cells around them\, watch the Tumours are complicated places video.” \n“In the Cancer Treatments playlist\, there are videos about all the various treatments I’ll be mentioning. The two I’d prioritise explain why we use small chemical compounds (small molecules) and antibodies as cancer treatments. If you have more time\, do also watch the videos on kinase inhibitors and immune checkpoint inhibitors.” \nAbout Elaine Vickers\nDr Elaine Vickers\nElaine Vickers of Science Communicated Ltd has a PhD in Molecular Biology. She has worked as a cancer educator for over twenty years. \nShe is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies\, and immunotherapies. \nElaine is experienced in teaching people with any level of scientific or medical knowledge. She particularly loves teaching nurses and other health professionals who might feel daunted by the idea of learning about cancer science. \nHer book\, A Beginner’s Guide to Targeted Cancer Treatments and Cancer Immunotherapy\, is now in its second edition. The first edition was Highly Commended by the British Medical Association book awards. \nElaine also makes short educational videos on cancer biology and treatments\, which you can find on her YouTube channel: https://www.youtube.com/@DrElaineVickers
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/targeted-treatments-and-immunotherapy-for-breast-cancer/
LOCATION:Virtual delivery via MS Teams
CATEGORIES:Cancer courses
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2024/09/3D-graphic-image-of-breast-banner-scaled.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
END:VCALENDAR